Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison

• Philip Mease,
• Ernest Choy,
• Peter Nash,
• Chrysostomos Kalyvas,
• Matthias Hunger,
• Luminita Pricop,
• Kunal K. Gandhi,
• Steffen M. Jugl,
• Howard Thom

Affiliations

Philip Mease

Swedish Medical Center and University of Washington, Seattle, WA, USA

Ernest Choy

CREATE Centre, Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK

Peter Nash

University of Queensland, Brisbane, Queensland, Australia

Chrysostomos Kalyvas

ICON plc (formerly Mapi Group), Houten, Netherlands

Matthias Hunger

ICON plc (formerly Mapi Group), Houten, Netherlands;ICON plc (formerly Mapi Group), Munich, Germany

Luminita Pricop

Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

Kunal K. Gandhi

Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

Steffen M. Jugl

Novartis Pharma AG, Basel, Switzerland

Howard Thom

University of Bristol, Bristol, UK